RemmersEF,PlengeRM,LeeAT,GrahamRR,HomG,BehrensTW, 2007.STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus,N Engl J Med 357 977 -86
OhnishiY,TsutsumiA,MatsumotoI,GotoD,ItoS,KuwanaM, 2006.Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients,Mod Rheumatol 16 226 -8
CopeAP, 2008.T cells in rheumatoid arthritis,Arthritis Res Ther 10 S1 -
LathamKA,WhittingtonKB,ZhouR,QianZ,RosloniecEF, 2005.Ex Vivo Characterisation of the Autoimmune T Cell Response in the HLADR1 Mouse Model of Collagen-Induced Arthritis Reveals LongTerm Activation of Type II Collagen-Specific Cells and Their Presence in Arthritic Joints,J Immunol 174 3978 -85
ChoiJJ,YooSA,ParkSJ,KangYJ, 2008.Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice,Clin ExpImmunol 153 269 -76
ZhuP,LiXY,WangHK,JiaJF,ZhengZH,DingJ, 2007.Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collageninduced arthritis,Clin Immunol 122 75 -84
DupontWD,PlummerWD, 1998.Power and Sample Size Calculations for Studies Involving Linear Regression,Control Clin Trials 19 589 -601
.ACR-endorsed Criteria for Rheumatic Diseases,[Cited 2017 Sept 14 -
AletahaD,SmolenJ, 2005.The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis,Clin Exp Rheumatol 23 S100 -8
MinSY,YanM,DuY,WuT,KhobahyE,KwonSR, 2013.Intraarticular nuclear factor-?B blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages,Clin ExpImmunol 172 217 -27
TeratoK,HarperDS,GriffithsMM,HastyDL,YeXJ,CremerMA, .Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen, -
1995.,Autoimmunity 22 137 -47
HeX,KangAH,StuartJM, 2000.Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis,J Rheumatol 27 589 -93
NissimA,WinyardPG,CorrigallV,FatahR,PerrettD,PanayiG, 2005.Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint,Arthritis Rheum 52 3829 -38
TrenthamDE,DynesiusRA,RocklinRE,DavidJR, 1978.Cellular sensitivity to collagen in rheumatoid arthritis,Trans Assoc Am Physicians 91 118 -28
TrenthamDE,Dynesius-TrenthamRA,OravEJ,CombitchiD,LorenzoC,SewellKL, 1993.Effects of oral administration of type II collagen on rheumatoid arthritis,Science 261 1727 -30
TrenthamDE,TownesAS,KangAH, 1977.Autoimmunity to type II collagen an experimental model of arthritis,J Exp Med 146 857 -68
StuartJM,PostlethwaiteAE,TownesAS,KangAH, 1980.Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases,Am J Med 69 13 -8
LondeiM,SavillCM,VerhoefA,BrennanF,LeechZA,DuanceV, 1989.Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis,Proc Natl Acad Sci USA 86 636 -40
DesaiBV,DixitS,PopeRM, 1989.Limited proliferative response to type II collagen in rheumatoid arthritis,J Rheumatol 16 1310 -4
SnowdenN,ReynoldsI,MorganK, 1997.T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls,Arthritis Rheum 40 1210 -8
HolmdahlR,AnderssonME,GoldschmidtTJ,JanssonL,KarlssonM,MalmströmV, 1989.Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity,APMIS 97 575 -84
MainoVC,SuniMA,RuitenbergJJ, 1995.Rapid flow cytometric method for measuring lymphocyte subset activation,Cytometry 20 127 -33
KubbiesM,SchindlerD,HoehnH,RabinovitchPS, 1985.BrdU-Hoechst flow cytometry reveals regulation of human lymphocyte growth by donor-age-related growth fraction and transition rate,J Cell Physiol 125 229 -34
ZhuP,LiXY,WangHK,JiaJF,ZhengZH,DingJ, 2007.Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collageninduced arthritis,Clin Immunol 122 75 -84
Von BaehrV,MayerW,LiebenthalC,von BaehrR,BiegerW,VolkHD, 2001.Improving the in vitro antigen specific T cell proliferation assay: the use of interferon-alpha to elicit antigen specific stimulation and decrease bystander proliferation,J Immunol Methods 251 63 -71
ZhuP,LiX,DingJ,FanC,WangY,WangH, .Simultaneous detection of DNA synthesis, activation and cytokine secretion in collagen II (250-270)-activated T lymphocytes by flow cytometry, -
2004.,Cell Biol Int 28 765 -72
Van der GraaffWL,PrinsAP,DijkmansBA,van LierRA., 1931.Prognostic value of Th1/Th2 ratio in rheumatoid arthritis,Lancet 351 -
2002.Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide,Eur J Pharmacol 453 325 -34
1997.,Cytometry 27 71 -6
NguyenXD,EichlerH,DugrillonA,PiechaczekC,BraunM,Klüter H, 2003.Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells,J Immunol Methods 275 57 -68
ChilsonOP,Kelly-ChilsonAE, 1989.Mitogeniclectins bind to the antigen receptor on human lymphocytes,Eur J Immunol 19 389 -96
DankeNA,KoelleDM,YeeC,BeherayS,KwokWW, 2004.Autoreactive T cells in healthy individuals,J Immunol 172 5967 -70